| Wendell Kevan Clarkston, MD | |
|
4320 Wornall Rd, Suite 240, Kansas City, MO 64111-5941 | |
| (816) 932-7940 | |
| Not Available |
| Full Name | Wendell Kevan Clarkston |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 40 Years |
| Location | 4320 Wornall Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144266248 | NPI | - | NPPES |
| 202516639 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 0429011 (Kansas) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | R1732 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Luke's South Hospital | Overland park, KS | Hospital |
| St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab (MT103) will be reported at the 53rd Annual American Society of Hematology (ASH) Annual Meeting, to be held December 10 - 13 in San Diego, California.
A new study in the American Journal of Hypertension indicates that postmenopausal women who have experienced tooth loss are at higher risk of developing high blood pressure. Multiple studies have suggested an association between periodontal disease and tooth loss with hypertension, but the relationship remains unclear.
Preliminary findings from a unique study with sunitinib suggest that it might be possible to tweak the dosage of chemotherapy drugs used to treat HIV-positive cancer patients to achieve therapeutic benefit. Given the type of drug cocktail patients use to treat their HIV, much more or considerably less chemotherapy may be warranted, say the researchers, part of the NCI-supported AIDS Malignancy Consortium (AMC). The trial design is being presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).
One of the most damaging misconceptions about drug use is that it is a permanent problem. The truth is that treatment for drug abuse can work, and can restore value and dignity to a person's life.
› Verified 2 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab (MT103) will be reported at the 53rd Annual American Society of Hematology (ASH) Annual Meeting, to be held December 10 - 13 in San Diego, California.
A new study in the American Journal of Hypertension indicates that postmenopausal women who have experienced tooth loss are at higher risk of developing high blood pressure. Multiple studies have suggested an association between periodontal disease and tooth loss with hypertension, but the relationship remains unclear.
Preliminary findings from a unique study with sunitinib suggest that it might be possible to tweak the dosage of chemotherapy drugs used to treat HIV-positive cancer patients to achieve therapeutic benefit. Given the type of drug cocktail patients use to treat their HIV, much more or considerably less chemotherapy may be warranted, say the researchers, part of the NCI-supported AIDS Malignancy Consortium (AMC). The trial design is being presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).
One of the most damaging misconceptions about drug use is that it is a permanent problem. The truth is that treatment for drug abuse can work, and can restore value and dignity to a person's life.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendell Kevan Clarkston, MD 901 E 104th St, Mailstop 400, Kansas City, MO 64131 Ph: (816) 599-9499 | Wendell Kevan Clarkston, MD 4320 Wornall Rd, Suite 240, Kansas City, MO 64111-5941 Ph: (816) 932-7940 |
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab (MT103) will be reported at the 53rd Annual American Society of Hematology (ASH) Annual Meeting, to be held December 10 - 13 in San Diego, California.
A new study in the American Journal of Hypertension indicates that postmenopausal women who have experienced tooth loss are at higher risk of developing high blood pressure. Multiple studies have suggested an association between periodontal disease and tooth loss with hypertension, but the relationship remains unclear.
Preliminary findings from a unique study with sunitinib suggest that it might be possible to tweak the dosage of chemotherapy drugs used to treat HIV-positive cancer patients to achieve therapeutic benefit. Given the type of drug cocktail patients use to treat their HIV, much more or considerably less chemotherapy may be warranted, say the researchers, part of the NCI-supported AIDS Malignancy Consortium (AMC). The trial design is being presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).
One of the most damaging misconceptions about drug use is that it is a permanent problem. The truth is that treatment for drug abuse can work, and can restore value and dignity to a person's life.
› Verified 2 days ago
Maria Akram Sheikh, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Dr. Philip Barigbi Augustine, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4150 N Mulberry Dr, Kansas City, MO 64116 Phone: 816-912-4539 Fax: 855-813-6642 | |
Lucas Vocelka, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd, Bldg 2, Suite 392, Kansas City, MO 64132 Phone: 816-444-7977 Fax: 630-528-9578 | |
Karla L Houston-gray, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr Ste 300, Kansas City, MO 64114 Phone: 816-942-4500 Fax: 816-941-4504 | |
Carl D Dirks, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Suite 65, Kansas City, MO 64111 Phone: 816-932-6100 Fax: 816-932-9002 | |
Michelle L Dew, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4330 Wornall Rd, Suite 2000, Kansas City, MO 64111 Phone: 816-931-1883 Fax: 816-756-3645 | |
Brenda J Rogers, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |